HIV protection drug lenacapavir 100% effective in women: Trial
(NewsNation) — One shot every six months successfully protected young women in Africa from HIV, early trial results from Gilead Sciences Inc. showed. The trial showed the new medication lenacapavir “demonstrated 100% efficacy as a preventive treatment” for HIV in cisgender women aged 16-25. The drug was used across 25 sites in South Africa and … Read more
